Bernstein Harold sold MAZE
January 5, 2026 · Form 4 insider transaction
Bernstein Harold sold 412 shares of Maze Therapeutics, Inc. at $40.00 per share, a transaction worth $16.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
412
Price
$40.00
Total value
$16.5K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.